Skip to main content
Terug
Watch Compare

Climb Bio, Inc.

Datakwaliteit: 83%
CLYM
NASDAQ Manufacturing Chemicals
€ 8,82
▲ € 0,17 (1,97%)
6 months return
—
Momentum
Neutral
ROE
-33,00%

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-33,00%
Boven sectorgemiddelde (-54,68%)
ROIC-29,50%
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
N/A
Current Ratio18,38
Interest CoverageN/A

Waardering

PE (TTM|NTM)
-8,86 | -5,92
Onder sectorgemiddelde (-1,49)
P/B Ratio3,00
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -54,54 M

Price History

Financiële Trends

Koersdoel Analisten

11 analisten
Buy
+74.2%
upside to target
Huidig
€ 8,82
Consensus Target
€ 15,36
€ 8,00
Laag
€ 26,00
Hoog
Vooruitzicht
Forward K/W
-5,92
Forward WPA
-€ 1,46
Omzet Sch.
0,0

Winstverassingen

EPS
Reported Estimate Forecast
Next: Q1 2026 · EPS Est: -€ 0,31 · Rev Est: 0,0
Q12025 Q22025 Q32025 Q42025 Q1 '26 Q2 '26
Reported -€ 0,31 -€ 0,13 -€ 0,19 -€ 0,26 — —
Estimate -€ 0,15 -€ 0,19 -€ 0,15 -€ 0,21 -€ 0,31 -€ 0,28
Verrassing -106,67% +29,73% -31,03% -25,80% — —

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: -33,00% · Net Margin: N/A
Revenue (TTM) N/A Net Income (TTM) -59,85 M
ROE -33,00% ROA -31,95%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -54,54 M
ROIC -29,50% FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: 18,38
Debt / Equity N/A Current Ratio 18,38
Interest Coverage N/A Asset Turnover N/A
Working Capital 86,02 M Tangible Book Value 177,00 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -8,86 · EV/EBITDA: N/A
P/E Ratio -8,86 Forward P/E -5,92
P/B Ratio 3,00 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -10,28%
Market Cap 530,47 M Enterprise Value 504,67 M

Per Share

EPS: -0,88 · FCF/Share: -0,80
EPS (Diluted TTM) -0,88 Revenue / Share N/A
FCF / Share -0,80 OCF / Share -0,80
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 91,13% · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion 91,13%
SBC-Adj. FCF -64,48 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -59,85 M -73,90 M -35,12 M -45,24 M -47,48 M
EPS (Diluted) -0,88 -1,53 -1,30 -1,72 —
Gross Profit — — — — —
Operating Income -67,88 M -82,02 M -40,28 M -45,14 M -35,67 M
EBITDA — — — — —
R&D Expenses 46,71 M 14,18 M 15,41 M 26,21 M 22,05 M
SG&A Expenses — — — — —
D&A 97.000,0 — — — —
Interest Expense — — — — —
Income Tax 0,0 0,0 0,0 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 167,74 M 217,19 M 110,47 M 134,99 M 173,24 M
Total Liabilities 7,27 M 5,31 M 2,87 M 6,28 M 6,04 M
Shareholders' Equity 160,48 M 211,88 M 107,60 M 128,72 M 167,20 M
Total Debt — — — — —
Cash & Equivalents 35,69 M 87,23 M 93,11 M 43,59 M 46,92 M
Current Assets 105,85 M 154,87 M 110,26 M 134,39 M 148,25 M
Current Liabilities 6,98 M 4,93 M 2,83 M 6,10 M 6,03 M

Sectorvergelijking

vs Manufacturing sector mediaan (1605 peers)
Metriek Aandeel Sector Mediaan
P/E -8,9 -1,5
P/B 3,0 1,6
ROE % -33,0 -54,7
Net Margin % — -41,5
Rev Growth 5Y % — 1,7
D/E — 0,3

ETFs Holding This Stock
BRUSX BRUSX
0,22% weight
BRSIX BRSIX
0,15% weight